BOI:EPA
Boiron
19,00 €
arrow_downward
-1,04%(-0,20) 1 d.
16. 11., 17:35:05 GMT+1 · EUR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre BOI…
Otvoriť
19,00 €
Vysoká
19,25 €
Nízka
18,95 €
Trh. kap.
333,36 mil.
Priem. obj.
4,76 tis.
Objem
1,59 tis.
Pomer cena/zárobky
12,60
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Otvoriť
19,00 €
Vysoká
19,25 €
Nízka
18,95 €
Trh. kap.
333,36 mil.
Priem. obj.
4,76 tis.
Objem
1,59 tis.
Pomer cena/zárobky
12,60
Max. za 52 týž.
32,25 €
Min. za 52 týž.
16,90 €
Výnosy na akciu
1,51 €
Akcie v obehu
17,55 mil.
Počet zamestnancov
3 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
Benzinga
·
pred 59 minútami
Here’s How Much You Would Have Made Owning iShares S&P 500 Growth ETF Stock In The Last 15 Years
Benzinga
·
pred 10 minútami
Forget Nvidia — S&P 500's 8,900 Target Puts These ETFs in Play - State Street SPDR S&P 500 ETF Trust (ARC
BigGo Finance
·
pred 2 hodinami
Bitget Opens Onchain Yield Vaults for Tokenized S&P 500, Nasdaq-100 Trackers
Traders Union
·
pred 1 hodinou
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profil
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
Informácie o subjekte Boiron
Generálny riaditeľ-
Zamestnanci2,62 tis.
Dátum založenia7. 6. 1932
Hlavné sídlo-
OdvetvieHealth Care
Odvetvie-
Webboiron.fr